atorvastatin has been researched along with ng-nitroarginine methyl ester in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (33.33) | 29.6817 |
| 2010's | 17 (62.96) | 24.3611 |
| 2020's | 1 (3.70) | 2.80 |
| Authors | Studies |
|---|---|
| Aragoncillo, P; Cachofeiro, V; Diaz, C; Hernández, G; Lahera, V; Maeso, R; Navarro-Cid, J; Ruilope, LM | 1 |
| Chen, J; Chopp, M; Feldkamp, CS; Jiang, H; Katakowski, M; Li, Y; Lu, M; Wang, L; Wang, Y; Zhang, C; Zhang, ZG | 1 |
| Ashitkov, T; Ballinger, S; Birnbaum, Y; Motamedi, M; Uretsky, BF | 1 |
| Bendhack, LM; Castro, MM; Nagassaki, S; Rascado, RR; Rizzi, E; Tanus-Santos, JE | 1 |
| Ahishali, B; Arican, N; Bilgic, B; Elmas, I; Kalayci, R; Kaya, M; Kucuk, M; Kudat, H; Uzun, H | 1 |
| Demova, H; Kluckova, H; Komers, R; Lecian, D; Lodererova, A; Teplan, V; Voska, L; Zdychova, J | 1 |
| Gryglewski, R; Hassan, M; Heeba, G; Khalifa, M; Malinski, T; Moselhy, ME | 1 |
| Brocheriou, I; Capron, F; Dupuis, M; Haloui, M; Louedec, L; Michel, JB; Nadaud, S; Soubrier, F | 1 |
| Kathirvel, K; Kuntamallappanavar, G; Leo, MD; Mishra, SK; Subramani, J; Uttam Singh, T | 1 |
| Bijjem, KV; Goyal, S; Kumar, S; Singh, M | 1 |
| Dehpour, AR; Fakhraei, N; Javadi-Paydar, M; Mirazi, N; Norouzi, A; Rayatnia, F; Zakeri, M | 1 |
| Allami, N; Dehpour, AR; Javadi-Paydar, M; Norouzi, A; Rastegar, H; Rayatnia, F; Zakeri, M | 1 |
| Holowatz, LA; Kenney, WL | 1 |
| Dehpour, AR; Fakhrzad, A; Hassanipour, M; Hassanpour, S; Moezi, L; Shafaroodi, H | 1 |
| Emamzadeh-Fard, S; Moazzami, K; Shabani, M | 1 |
| Ai, J; Ban, X; Niu, H; Sun, L; Wang, N; Xu, Y; Yang, B; Yu, Y; Zhang, R; Zhao, R | 1 |
| Dehpour, AR; Fakhrzad, A; Hassanipour, M; Moezi, L; Rezayat, M; Shafaroodi, H | 1 |
| Erkoseoglu, I; Kadioglu, M; Kalyoncu, NI; Kesim, M; Muci, E; Okuyan, M; Yaris, E | 1 |
| Cai, A; Dong, Y; Feng, Y; Huang, Y; Mai, W; Qiu, R; Rao, S; Yu, D; Zheng, D; Zhou, Y | 1 |
| Bi, XY; He, X; Yu, XJ; Zang, WJ; Zhao, M | 1 |
| Arican, N; Gelisgen, R; Kalayci, R; Kaya, M; Konukoglu, D; Sozer, V; Tabak, O; Uzun, H | 1 |
| Chaudagar, KK; Mehta, AA | 1 |
| Cai, Y; Fan, Z; Feng, J; Jiang, F; Li, J; Liu, X; Ma, D; Zha, K; Zheng, S | 1 |
| Dehpour, A; Jahanabadi, S; Javadi, S; Khoshnoodi, M; Mehr, SE; Shafaroodi, H; Shahsavarian, A; Shamsaee, J | 1 |
| Botelho, T; de Batista, PR; Padilha, AS; Ribeiro-Júnior, RF; Simões, FV; Vassallo, DV | 1 |
| Amini-Khoei, H; Dehpour, A; Hassanipour, M; Imran-Khan, M; Rahimi, N; Rezayat, SM; Shafaroodi, H; Shirzadian, A | 1 |
| Abdollahi, A; Akbarian, R; Chamanara, M; Dehpour, AR; Ejtemaei Mehr, S; Rashidian, A | 1 |
1 trial(s) available for atorvastatin and ng-nitroarginine methyl ester
| Article | Year |
|---|---|
Acute localized administration of tetrahydrobiopterin and chronic systemic atorvastatin treatment restore cutaneous microvascular function in hypercholesterolaemic humans.
Topics: Anticholesteremic Agents; Arginase; Arginine; Atorvastatin; Biopterins; Cholesterol; Female; Heating; Heptanoic Acids; Humans; Hypercholesterolemia; Lipoproteins, LDL; Male; Microcirculation; Microdialysis; Middle Aged; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Pyrroles; Regional Blood Flow; Skin; Vasodilation | 2011 |
26 other study(ies) available for atorvastatin and ng-nitroarginine methyl ester
| Article | Year |
|---|---|
Effect of atorvastatin on endothelium-dependent constrictor factors in dyslipidemic rabbits.
Topics: Animals; Anticholesteremic Agents; Aorta; Atorvastatin; Drug Interactions; Endothelins; Endothelium, Vascular; Enzyme Inhibitors; Heptanoic Acids; Hyperlipidemias; Male; NG-Nitroarginine Methyl Ester; Pyrroles; Rabbits; Receptor, Endothelin A; Receptors, Endothelin; Receptors, Prostaglandin; Receptors, Thromboxane A2, Prostaglandin H2; Vasoconstriction | 2000 |
Statins induce angiogenesis, neurogenesis, and synaptogenesis after stroke.
Topics: Animals; Antibodies; Atorvastatin; Brain; Enzyme Inhibitors; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunohistochemistry; Male; Mitogen-Activated Protein Kinases; Neovascularization, Physiologic; Neuronal Plasticity; Neurons; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Phosphorylation; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Pyrroles; Rats; Rats, Wistar; Signal Transduction; Stroke; Synapses; Vascular Endothelial Growth Factor Receptor-2 | 2003 |
Reduction of infarct size by short-term pretreatment with atorvastatin.
Topics: Animals; Atorvastatin; Dose-Response Relationship, Drug; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; NG-Nitroarginine Methyl Ester; Pyrroles; Rats; Rats, Sprague-Dawley | 2003 |
Atorvastatin enhances sildenafil-induced vasodilation through nitric oxide-mediated mechanisms.
Topics: Analysis of Variance; Animals; Anticholesteremic Agents; Aorta, Thoracic; Atorvastatin; Blood Pressure; Dose-Response Relationship, Drug; Enzyme Inhibitors; Heptanoic Acids; In Vitro Techniques; Male; NG-Nitroarginine Methyl Ester; Nitrates; Nitric Acid; Nitric Oxide Synthase; Nitrites; Piperazines; Purines; Pyrroles; Rats; Rats, Wistar; Sildenafil Citrate; Sulfones; Vasodilation; Vasodilator Agents | 2004 |
Effects of atorvastatin on blood-brain barrier permeability during L-NAME hypertension followed by angiotensin-II in rats.
Topics: Angiotensin II; Animals; Atorvastatin; Blood-Brain Barrier; Heptanoic Acids; Hypertension; Male; NG-Nitroarginine Methyl Ester; Permeability; Pyrroles; Rats; Rats, Wistar | 2005 |
Renal effects of HMG-CoA reductase inhibition in a rat model of chronic inhibition of nitric oxide synthesis.
Topics: Albuminuria; Analysis of Variance; Animals; Atorvastatin; Blood Pressure; Caveolin 1; Glomerular Filtration Rate; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Kidney Diseases; Kidney Glomerulus; Male; Models, Animal; NG-Nitroarginine Methyl Ester; Nitric Oxide; Pyrroles; Rats; Rats, Wistar; rhoA GTP-Binding Protein; Vascular Endothelial Growth Factor A | 2006 |
Anti-atherogenic effect of statins: role of nitric oxide, peroxynitrite and haem oxygenase-1.
Topics: Animals; Aorta; Arginine; Atherosclerosis; Atorvastatin; Disease Models, Animal; Endothelium, Vascular; Enzyme Inhibitors; Heme Oxygenase-1; Hemin; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipid Peroxidation; Male; Malondialdehyde; Metalloporphyrins; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Peroxynitrous Acid; Protoporphyrins; Pyrroles; Rabbits; Simvastatin; Time Factors | 2009 |
Counter-regulation by atorvastatin of gene modulations induced by L-NAME hypertension is associated with vascular protection.
Topics: Animals; Aorta; Atorvastatin; Endothelium, Vascular; Gene Expression Regulation; Heptanoic Acids; Hypertension; Male; NG-Nitroarginine Methyl Ester; Pyrroles; Rats; Rats, Inbred F344 | 2009 |
Atorvastatin restores the impaired vascular endothelium-dependent relaxations mediated by nitric oxide and endothelium-derived hyperpolarizing factors but not hypotension in sepsis.
Topics: Acetylcholine; Animals; Aorta; Atorvastatin; Biological Factors; Blood Cell Count; Blood Pressure; Calcium Channel Blockers; Cytochrome P-450 Enzyme Inhibitors; Disease Models, Animal; Endothelium, Vascular; Gene Expression; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypotension; Indomethacin; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Nitrites; Nitroprusside; Phenylephrine; Pulmonary Artery; Pyrroles; Rats; Rats, Wistar; Sepsis; Vasodilation | 2009 |
Role of glucagon-like peptide- 1 in vascular endothelial dysfunction.
Topics: Animals; Atorvastatin; Diabetes Mellitus, Experimental; Endothelium, Vascular; Exenatide; Female; Glucagon-Like Peptide 1; Heptanoic Acids; Hyperhomocysteinemia; In Vitro Techniques; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Peptides; Pyrroles; Rats; Rats, Wistar; Venoms | 2010 |
Atorvastatin improved scopolamine-induced impairment in memory acquisition in mice: involvement of nitric oxide.
Topics: Animals; Arginine; Atorvastatin; Cholinergic Antagonists; Disease Models, Animal; Enzyme Inhibitors; Guanidines; Heptanoic Acids; Learning Disabilities; Memory; Memory Disorders; Mice; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Pyrroles; Scopolamine | 2011 |
Nitric oxide involvement in consolidation, but not retrieval phase of cognitive performance enhanced by atorvastatin in mice.
Topics: Animals; Arginine; Atorvastatin; Cognition; Drug Antagonism; Drug Synergism; Guanidines; Heptanoic Acids; Memory; Memory Disorders; Mice; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Pyrroles; Scopolamine; Spatial Behavior | 2011 |
Chronic administration of atorvastatin induced anti-convulsant effects in mice: the role of nitric oxide.
Topics: Analysis of Variance; Animals; Anticonvulsants; Atorvastatin; Convulsants; Disease Models, Animal; Drug Administration Routes; Drug Administration Schedule; Drug Interactions; Enzyme Inhibitors; Guanidines; Heptanoic Acids; Male; Mice; NG-Nitroarginine Methyl Ester; Nitric Oxide; Pentylenetetrazole; Pyrroles; Seizures; Time Factors | 2012 |
Anticonvulsive effect of atorvastatin on pentylenetetrazole-induced seizures in mice: the role of nitric oxide pathway.
Topics: Animals; Anticonvulsants; Arginine; Atorvastatin; Heptanoic Acids; Male; Mice; NG-Nitroarginine Methyl Ester; Nitric Oxide; Pentylenetetrazole; Pyrroles; Seizures; Signal Transduction | 2013 |
Daming capsule restores endothelial dysfunction induced by high-fat diet.
Topics: Animals; Anticholesteremic Agents; Aorta, Thoracic; Atorvastatin; Diet, High-Fat; Drugs, Chinese Herbal; Endothelium, Vascular; Enzyme Inhibitors; Heptanoic Acids; Hyperlipidemias; Hypolipidemic Agents; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Phytotherapy; Potassium Channels; Pyrroles; Rats; Rats, Wistar; Vascular Diseases; Vasoconstriction; Vasodilation | 2012 |
The involvement of nitric oxide in the anti-seizure effect of acute atorvastatin treatment in mice.
Topics: Animals; Anticonvulsants; Atorvastatin; Brain; Convulsants; Disease Models, Animal; Dose-Response Relationship, Drug; Electroshock; Enzyme Inhibitors; Epilepsy, Tonic-Clonic; Guanidines; Heptanoic Acids; Male; Mice; NG-Nitroarginine Methyl Ester; Nitric Oxide; Pentylenetetrazole; Pyrroles | 2012 |
The evaluation of analgesic effects of simvastatin, pravastatin and atorvastatin in hot plate test.
Topics: Analgesics; Animals; Atorvastatin; Female; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Mice; Mice, Inbred BALB C; Naloxone; NG-Nitroarginine Methyl Ester; Pravastatin; Pyrroles; Simvastatin | 2012 |
SDF-1α upregulation by atorvastatin in rats with acute myocardial infarction via nitric oxide production confers anti-inflammatory and anti-apoptotic effects.
Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Atorvastatin; Benzylamines; Chemokine CXCL12; Coronary Vessels; Cyclams; Heptanoic Acids; Heterocyclic Compounds; Ligation; Male; Myocardial Infarction; NG-Nitroarginine Methyl Ester; Nitric Oxide; Pyrroles; Rats; Rats, Sprague-Dawley; Receptors, CXCR4; STAT3 Transcription Factor; Up-Regulation | 2012 |
Role of endothelial nitric oxide synthase and vagal activity in the endothelial protection of atorvastatin in ischemia/reperfusion injury.
Topics: Acetylcholine; Animals; Apoptosis; Atorvastatin; Endothelium, Vascular; Enzyme Inhibitors; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Mesenteric Artery, Superior; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type III; Phosphatidylinositol 3-Kinase; Pyrroles; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Vagus Nerve; Vasoconstrictor Agents | 2013 |
The effects of atorvastatin on oxidative stress in L-NAME-treated rats.
Topics: Animals; Aryldialkylphosphatase; Atorvastatin; Drug Evaluation, Preclinical; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Lipid Peroxidation; Lipids; Male; NG-Nitroarginine Methyl Ester; Oxidative Stress; Protein Carbonylation; Pyrroles; Rats; Rats, Wistar; Sulfhydryl Compounds | 2013 |
Effect of atorvastatin on the angiogenic responsiveness of coronary endothelial cells in normal and streptozotocin (STZ) induced diabetic rats.
Topics: Androstadienes; Animals; Anticholesteremic Agents; Atorvastatin; Benzophenanthridines; Chick Embryo; Chorioallantoic Membrane; Coronary Vessels; Diabetes Mellitus, Experimental; Endothelial Cells; Enzyme Inhibitors; Heptanoic Acids; Male; Myocardial Reperfusion Injury; Neovascularization, Physiologic; NG-Nitroarginine Methyl Ester; Nitric Oxide; Pyrroles; Rats; Rats, Wistar; Streptozocin; Vascular Endothelial Growth Factor A; Wortmannin | 2014 |
The roles of nitric oxide and hydrogen sulfide in the anti-atherosclerotic effect of atorvastatin.
Topics: Alkynes; Animals; Aorta, Thoracic; Atherosclerosis; Atorvastatin; Diet, High-Fat; Glycine; Heptanoic Acids; Hydrogen Sulfide; NG-Nitroarginine Methyl Ester; Nitric Oxide; Pyrroles; Rats, Sprague-Dawley | 2015 |
Antidepressant-like effect of atorvastatin in the forced swimming test in mice: the role of PPAR-gamma receptor and nitric oxide pathway.
Topics: Anilides; Animals; Antidepressive Agents; Atorvastatin; Depression; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Imipramine; Male; Mice; Motor Activity; NG-Nitroarginine Methyl Ester; Nitric Oxide; Pioglitazone; PPAR gamma; Pyrroles; Signal Transduction; Swimming; Thiazolidinediones | 2014 |
Treatment with high dose of atorvastatin reduces vascular injury in diabetic rats.
Topics: Animals; Aorta; Atorvastatin; Cyclooxygenase 2; Diabetes Mellitus, Experimental; Endothelium, Vascular; Indomethacin; Male; NADPH Oxidases; NG-Nitroarginine Methyl Ester; Nitrobenzenes; Phenylephrine; Prostaglandins; Rats; Rats, Wistar; Streptozocin; Sulfonamides; Superoxides; Vascular System Injuries; Vasodilation; Vasodilator Agents | 2016 |
Atorvastatin attenuates the antinociceptive tolerance of morphine via nitric oxide dependent pathway in male mice.
Topics: Animals; Arginine; Atorvastatin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Tolerance; Enzyme Inhibitors; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Mice; Morphine; Narcotics; NG-Nitroarginine Methyl Ester; Nitric Oxide; Opioid-Related Disorders; Pain Measurement; Pain Threshold; Signal Transduction | 2016 |
Atorvastatin prevents the development of diabetic neuropathic nociception by possible involvement of nitrergic system.
Topics: Animals; Atorvastatin; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nociception; Rats; Streptozocin | 2021 |